Associate Scientist, Biomolecular InterAction Core
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking an Associate Scientist to join our Biomolecular InterAction Core group, supporting our Therapeutic Proteins team in an on-site capacity. In this role, you will implement methods to characterize protein interactions and biochemical properties in support of our antibody pipeline, while collaborating with colleagues across the group and the wider organization.
Job description
Build our future together
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking an Associate Scientist to join our Biomolecular InterAction Core group, supporting our Therapeutic Proteins team in an on-site capacity. In this role, you will implement methods to characterize protein interactions and biochemical properties in support of our antibody pipeline, while collaborating with colleagues across the group and the wider organization.
Discover your role
- Characterize antibodies, develop methods, and provide analytical support for biologics development
- Implement methods to characterize protein interactions and biochemical properties
- Troubleshoot established test methods used in development and release testing of screening reagents
- Tabulate results and write summary reports of assay development
- Present findings at group meetings and, possibly, interdepartmental meetings
- Maintain lab supplies and equipment
- Produce and maintain accurate records
This role requires
- BS/MS in Molecular Biology, Cell Biology, or a related field and 0-3 years of relevant laboratory experience
- Knowledge of protein chemistry and biophysical methods, including spectroscopic and calorimetric techniques, SPR (Biacore), BLI (Octet), and ITC
- Experience with chromatography and electrophoretic analysis of proteins, including HPLC, FPLC, SDS-PAGE, and Western blot
- Experience developing immunoassays (ELISA and RIA)
- Strong oral and written communication skills and proficiency in word processing, spreadsheet, and database management
- Excellent organizational and interpersonal skills
Requirements
- BS/MS in Molecular Biology, Cell Biology, or a related field
- 0-3 years of relevant laboratory experience
- Knowledge of protein chemistry and biophysical methods
- Spectroscopic and calorimetric techniques
- SPR (Biacore), BLI (Octet), and ITC
- Chromatography and electrophoretic analysis of proteins
- HPLC, FPLC, SDS-PAGE, and Western blot
- Experience developing immunoassays (ELISA and RIA)
- Strong oral and written communication skills
- Proficiency in word processing, spreadsheet, and database management
- Excellent organizational and interpersonal skills
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.